BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR

被引：0
|
作者：
Jansen, L. [1 ]
Takkenberg, R. B. [1 ]
de Niet, A. [1 ]
Zaaijer, H. L. [1 ,2 ]
Weegink, C. J. [1 ]
Terpstra, V. [3 ]
Dijkgraaf, M. G. W. [4 ]
Molenkamp, R. [1 ]
Janssen, P. L. M. [1 ]
Koot, M. [5 ]
Rijckborst, V. [6 ]
Janssen, H. L. A. [6 ]
Beld, M. G. H. M. [1 ]
Reesink, H. W. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Sanquin, Blood Borne Infect, Amsterdam, Netherlands
[3] Bronovo Hosp, The Hague, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands
[5] Sanquin, Virus Diagnost Serv, Amsterdam, Netherlands
[6] Univ Rotterdam Hosp, Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60755-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
753
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [1] BASELINE HBsAg LEVEL PREDICT HBsAg LOSS IN CHRONIC HEPATITIS B PATIENTS TREATED WITH A COMBINATION OF PEGINTERFERON ALFA-2A AND ADEFOVIR: AN INTERIM ANALYSIS
    Takkenberg, B.
    Zaaijer, H.
    Weegink, C.
    Terpstra, V.
    Dijkgraaf, M.
    Jansen, P.
    Janssen, H.
    Beld, M.
    Reesink, H.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S8 - S8
  • [2] HIGH RATE OF HBSAG LOSS AND HBSAG SEROCONVERSION IN CHRONIC HEPATITIS B PATIENTS ON COMBINATION THERAPY WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA®): HBSAG TITER PREDICTS HBSAG LOSS OR SEROCONVERSION
    Takkenberg, Bart
    Zaaijer, Hans L.
    Weegink, Christine J.
    Terpstra, Volesko
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2008, 48 (04) : 1026A - 1027A
  • [3] INTRAHEPATIC HBSAG PREDICTS TREATMENT RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR: AN INTERIM ANALYSIS
    Takkenberg, Bart
    Terpstra, Valeska
    Zaaijer, Hans L.
    Weegink, Christine J.
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2010, 52 (04) : 988A - 988A
  • [4] BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 536A - 537A
  • [5] INTRAHEPATIC HBSAG PREDICTS TREATMENT RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR; AN INTERIM ANALYSIS
    Takkenberg, B.
    De Niet, A.
    Terpstra, V.
    Zaaijer, H.
    Weegink, C.
    Koot, M.
    Dijkgraaf, M.
    Jansen, P.
    Beld, M.
    Reesink, H.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S397 - S397
  • [6] BASELINE HBSAG AS PREDICTOR FOR HBSAG SEROCONVERSION IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR: FINAL RESULTS OF A PROSPECTIVE OPEN LABEL STUDY
    Takkenberg, Bart
    de Niet, Annikki
    Zaaijer, Hans L.
    Weegink, Christine J.
    Terpstra, Valeska
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Rijckborst, Vincent
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2011, 54 : 1039A - 1040A
  • [7] NK CELL DYNAMICS IN CHRONIC HEPATITIS B PATIENTS ARE ASSOCIATED WITH HBsAg CLEARANCE AFTER COMBINATION TREATMENT WITH PEGINTERFERON ALFA-2A AND ADEFOVIR
    Stelma, F.
    de Niet, A.
    Jansen, L.
    Takkenberg, R. B.
    Janssen, H. L.
    Sinnige, M. J.
    Kootstra, N. A.
    van Leeuwen, E. M.
    Reesink, H. W.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S498 - S498
  • [8] HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5years of follow-up
    Stelma, F.
    van der Ree, M. H.
    Jansen, L.
    Peters, M. W.
    Janssen, H. L. A.
    Zaaijer, H. L.
    Takkenberg, R. Bart
    Reesink, H. W.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (12) : 1107 - 1113
  • [9] BASELINE HBSAG LEVEL AND ON-TREATMENT HBSAG AND HBV DNA DECLINE PREDICT SUSTAINED VIROLOGICAL RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA); AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 538A - 539A
  • [10] High Rate of HBsAg Loss After Peginterferon Based Combination Treatment for Chronic Hepatitis B Patients: Results After 5 Years of Follow-up
    Stelma, Femke
    van der Ree, Meike H.
    Peters, Martine W.
    Jansen, Louis
    de Niet, Annikki
    Janssen, Harry L.
    Zaaijer, Hans L.
    Takkenberg, R. B.
    Reesink, Hendrik W.
    HEPATOLOGY, 2016, 64 : 911A - 912A
12345